Np mrd loader

Record Information
Version1.0
Created at2021-11-12 23:53:27 UTC
Updated at2021-11-26 17:46:04 UTC
NP-MRD IDNP0044158
Secondary Accession NumbersNone
Natural Product Identification
Common NameLigupurpurposide K
Description(2S)-2beta-(beta-D-Glucopyranosyloxy)-5-carboxy-3,4-dihydro-2H-pyran-3alpha,4alpha-bisacetic acid 4-[2-(4-hydroxyphenyl)ethyl] ester belongs to the class of organic compounds known as terpene glycosides. These are prenol lipids containing a carbohydrate moiety glycosidically bound to a terpene backbone. It was first documented in 2020 (PMID: 34756847). Based on a literature review a significant number of articles have been published on (2S)-2beta-(beta-D-Glucopyranosyloxy)-5-carboxy-3,4-dihydro-2H-pyran-3alpha,4alpha-bisacetic acid 4-[2-(4-hydroxyphenyl)ethyl] ester (PMID: 34758548) (PMID: 34758547) (PMID: 34758546) (PMID: 34758545).
Structure
Thumb
Synonyms
ValueSource
(2S)-2b-(b-D-Glucopyranosyloxy)-5-carboxy-3,4-dihydro-2H-pyran-3a,4a-bisacetate 4-[2-(4-hydroxyphenyl)ethyl] esterGenerator
(2S)-2b-(b-D-Glucopyranosyloxy)-5-carboxy-3,4-dihydro-2H-pyran-3a,4a-bisacetic acid 4-[2-(4-hydroxyphenyl)ethyl] esterGenerator
(2S)-2beta-(beta-D-Glucopyranosyloxy)-5-carboxy-3,4-dihydro-2H-pyran-3alpha,4alpha-bisacetate 4-[2-(4-hydroxyphenyl)ethyl] esterGenerator
(2S)-2Β-(β-D-glucopyranosyloxy)-5-carboxy-3,4-dihydro-2H-pyran-3α,4α-bisacetate 4-[2-(4-hydroxyphenyl)ethyl] esterGenerator
(2S)-2Β-(β-D-glucopyranosyloxy)-5-carboxy-3,4-dihydro-2H-pyran-3α,4α-bisacetic acid 4-[2-(4-hydroxyphenyl)ethyl] esterGenerator
Chemical FormulaC24H30O14
Average Mass542.4900 Da
Monoisotopic Mass542.16356 Da
IUPAC Name(2S,3R,4S)-3-(carboxymethyl)-4-{2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl}-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-pyran-5-carboxylic acid
Traditional Name(4S,5R,6S)-5-(carboxymethyl)-4-{2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl}-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4H-pyran-3-carboxylic acid
CAS Registry NumberNot Available
SMILES
OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@@H](CC(=O)OCCC3=CC=C(O)C=C3)[C@H]2CC(O)=O)C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
InChI Identifier
InChI=1S/C24H30O14/c25-9-16-19(30)20(31)21(32)24(37-16)38-23-14(7-17(27)28)13(15(10-36-23)22(33)34)8-18(29)35-6-5-11-1-3-12(26)4-2-11/h1-4,10,13-14,16,19-21,23-26,30-32H,5-9H2,(H,27,28)(H,33,34)/t13-,14+,16+,19+,20-,21+,23-,24-/m0/s1
InChI KeySBEDHFVHKZQSJG-ONNLFQHFSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 50 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 150 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 250 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 175 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 100 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 225 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 200 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 125 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 25 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, Methanol-d4, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of Origin
  • Ligustrum purpurascens
  • Chemical Taxonomy
    Description Belongs to the class of organic compounds known as terpene glycosides. These are prenol lipids containing a carbohydrate moiety glycosidically bound to a terpene backbone.
    KingdomOrganic compounds
    Super ClassLipids and lipid-like molecules
    ClassPrenol lipids
    Sub ClassTerpene glycosides
    Direct ParentTerpene glycosides
    Alternative Parents
    Substituents
    • Terpene glycoside
    • O-glycosyl compound
    • Secoiridoid-skeleton
    • Glycosyl compound
    • Tyrosol derivative
    • Monoterpenoid
    • Monocyclic monoterpenoid
    • Aromatic monoterpenoid
    • Tricarboxylic acid or derivatives
    • 1-hydroxy-2-unsubstituted benzenoid
    • Sugar acid
    • Phenol
    • Benzenoid
    • Oxane
    • Monosaccharide
    • Monocyclic benzene moiety
    • Vinylogous ester
    • Secondary alcohol
    • Carboxylic acid ester
    • Oxacycle
    • Organoheterocyclic compound
    • Polyol
    • Carboxylic acid
    • Carboxylic acid derivative
    • Acetal
    • Organic oxygen compound
    • Organic oxide
    • Hydrocarbon derivative
    • Primary alcohol
    • Organooxygen compound
    • Carbonyl group
    • Alcohol
    • Aromatic heteromonocyclic compound
    Molecular FrameworkAromatic heteromonocyclic compounds
    External DescriptorsNot Available
    Physical Properties
    StateNot Available
    Experimental Properties
    PropertyValueReference
    Melting PointNot AvailableNot Available
    Boiling PointNot AvailableNot Available
    Water SolubilityNot AvailableNot Available
    LogPNot AvailableNot Available
    Predicted Properties
    PropertyValueSource
    logP-0.24ALOGPS
    logP-1.1ChemAxon
    logS-2.4ALOGPS
    pKa (Strongest Acidic)3.62ChemAxon
    pKa (Strongest Basic)-3ChemAxon
    Physiological Charge-2ChemAxon
    Hydrogen Acceptor Count13ChemAxon
    Hydrogen Donor Count7ChemAxon
    Polar Surface Area229.74 ŲChemAxon
    Rotatable Bond Count12ChemAxon
    Refractivity122.42 m³·mol⁻¹ChemAxon
    Polarizability52.77 ųChemAxon
    Number of Rings3ChemAxon
    BioavailabilityNoChemAxon
    Rule of FiveNoChemAxon
    Ghose FilterNoChemAxon
    Veber's RuleNoChemAxon
    MDDR-like RuleYesChemAxon
    HMDB IDNot Available
    DrugBank IDNot Available
    Phenol Explorer Compound IDNot Available
    FoodDB IDNot Available
    KNApSAcK IDNot Available
    Chemspider IDNot Available
    KEGG Compound IDNot Available
    BioCyc IDNot Available
    BiGG IDNot Available
    Wikipedia LinkNot Available
    METLIN IDNot Available
    PubChem Compound122383066
    PDB IDNot Available
    ChEBI IDNot Available
    Good Scents IDNot Available
    References
    General References
    1. McDonagh MS, Wagner J, Ahmed AY, Morasco B, Kansagara D, Chou R: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain - Quarterly Progress Report/Addendum: September 2021. 2020 Dec. [PubMed:34756847 ]
    2. Zhang WB, Yang QB, Wu SF, Lu SH, Cheng M, Sheng Y, Zhang QC, Yang LF, Yu L, Yan SX: [Application of diffusion-weighted magnetic resonance imaging in evaluating the efficacy of radiotherapy and chemotherapy for esophageal cancer]. Zhonghua Yi Xue Za Zhi. 2021 Nov 9;101(41):3427-3430. doi: 10.3760/cma.j.cn112137-20210709-01544. [PubMed:34758548 ]
    3. Sun Y, Wang DM, Yu H, Liu C, Ji TY, Wang S, Wu Y, Liu XY, Jiang YW, Cai LX, Liu QZ: [The screening of potential biological markers of seizure onset zone in focal cortical dysplasia based on bioinformatics analysis]. Zhonghua Yi Xue Za Zhi. 2021 Nov 9;101(41):3422-3426. doi: 10.3760/cma.j.cn112137-20210331-00779. [PubMed:34758547 ]
    4. Dong HH, Cai YS, Liang XN, Miao JB, Chen QS, Gao YD, Li H: [Analysis of incidence and risk factors for postoperative venous thromboembolism in patients with stage a non-small-cell lung cancer]. Zhonghua Yi Xue Za Zhi. 2021 Nov 9;101(41):3417-3421. doi: 10.3760/cma.j.cn112137-20210418-00929. [PubMed:34758546 ]
    5. Chai YR, Gao JB, Lyu PJ, Liang P, Xing JJ, Liu J: [Comparative study of CT relative enhancement value and subjective visual evaluation for intestinal ischemia in patients with closed loop obstruction]. Zhonghua Yi Xue Za Zhi. 2021 Nov 9;101(41):3411-3416. doi: 10.3760/cma.j.cn112137-20210328-00756. [PubMed:34758545 ]
    6. Long Fan et al. (2015). Phenylethanoid and secoiridoid glycosides from the leaves of Ligustrum purpurascens. Phytochemistry Letters, Volume 13, September 2015, Pages 177-181. DOI: 10.1016/j.phytol.2015.06.011. Phytochemistry Letters.